← Leaderboards
Dingcheng Gao
Weill Medical Coll Of Cornell Univ
$4,134,819
Attributed
$4,134,819
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $851.7K · FY2016–24$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,134,819 · 2
By mechanism
R01$4,134,819 · 2
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Sarah Marie Cheal$3,628,213
- Nadia Dahmane$3,298,274
- Bishoy Morris Faltas$1,464,409
- James Charles Hart$196,102
- Benedict Shek Hang Law$4,167,074
Others in their field
Top investigators on “Transcription Factor”
- Michael P Snyder · Yale University$110,571,583
- Richard M Myers · Hudson-Alpha Institute For Biotechnology$57,320,347
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$55,523,574
- Angela M. Gronenborn · Diabetes, Digestive, Kidney Diseases$45,640,184
- Richard K. Wilson · Washington University$45,224,621
- Deborah Nickerson · University Of Washington$35,131,320
Research focus
Transcription FactorTransdifferentiationSnailsStemnessResistanceProgramsGeneticMediatingNeoplastic CellNeoplasm MetastasisEventPhenotypeFluorescencePrimary NeoplasmChemotherapyEpithelial To Mesenchymal TransitionIn VivoClustered Regularly Interspaced Short Palindromic RepeatsE-CadherinMesenchymalMetastatic Neoplasm To The LungMouse Mammary Tumor VirusApoptosisTumor Progression
Grant awards (10)
To study the EMT contributions in tumor metastasis and chemoresistance by using lineage tracing models$464,556
R01 · FY2024 · CA · contact PI
To study the EMT contributions in tumor metastasis and chemoresistance by using lineage tracing models$479,228
R01 · FY2023 · CA · contact PI
To study the EMT contributions in tumor metastasis and chemoresistance by using lineage tracing models$479,228
R01 · FY2022 · CA · contact PI
To study the EMT contributions in tumor metastasis and chemoresistance by using lineage tracing models$489,007
R01 · FY2021 · CA · contact PI
To study the EMT contributions in tumor metastasis and chemoresistance by using lineage tracing models$506,382
R01 · FY2020 · CA · contact PI
Targeting the epithelial to mesenchymal transition-mediated chemoresistance in breast cancer$345,356
R01 · FY2020 · CA · contact PI
Targeting the epithelial to mesenchymal transition-mediated chemoresistance in breast cancer$334,994
R01 · FY2019 · CA · contact PI
Targeting the epithelial to mesenchymal transition-mediated chemoresistance in breast cancer$345,356
R01 · FY2018 · CA · contact PI
Targeting the epithelial to mesenchymal transition-mediated chemoresistance in breast cancer$345,356
R01 · FY2017 · CA · contact PI
Targeting the epithelial to mesenchymal transition-mediated chemoresistance in breast cancer$345,356
R01 · FY2016 · CA · contact PI